Authors




Aida Vega, MD

Latest:

Improved Diabetes and Kidney Function Control With KidneyIntelX

Drs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.


Sarah Hallberg, DO, MS

Latest:

Vaccines are Crucial for At-risk Populations

It is critical for physicians to urge patients with obesity to get vaccinated against COVID-19 as they are one of the highest risk patient populations.


Rose McNulty

Latest:

Atrial Fibrillation in the US 3-Fold More Prevalent Than Previously Estimated, New Data Suggest

Approximately 10.5 million US adults, or 5% of the population, have the atrial fibrillation, according to new prevalence estimates.


Steven E. Nissen, MD, MACC

Latest:

Role of Bempedoic Acid in Clinical Practice

Experts discuss key takeaways from the review article “Role of Bempedoic Acid in Clinical Practice”, clinical implications, and the greatly anticipated CLEAR Outcomes trial.


Linda Girgis, MD

Latest:

How to Handle Medical Misinformation in the Clinic

These tips from a family physician on managing misinformation in the exam room can help reduce the spread of false and misleading narratives.


Hayden E. Klein

Latest:

Strong Link Between Increasing Lp(a) Level and Recurrent ASCVD Events Makes Screening Essential, Investigator Warns

A continuous increase in ASCVD risk was seen with higher levels of lipoprotein(a) in the largest study to date of the relationship.


Suzanne Cuda, MD

Latest:

To Fight Childhood Obesity, Use the Best Tools Available

Obesity affects nearly 20% of US children, impacting both current and future health. The 2020 update of the Pediatric Obesity Algorithm provides expert treatment guidance.



Joseph Elengickal

Latest:

Medical Students Augment Accurate Information During Pandemic

Students from the Medical College of Georgia, unable to care directly for COVID-19 patients, combined their individual skills to keep accurate information flowing.


Matt Hoffman

Latest:

First Biosimilar for Multiple Sclerosis Wins FDA Approval

The first biosimilar to the approved formulation of natalizumab is indicated for relapsing forms of MS and for induction/maintenance of remission in adults with Crohn disease.


Alex Evans, PharmD, MBA

Latest:

Mental Health & Cardiovascular Disease: What's the Link?

What does the latest research say about the association between mental health and cardiovascular disease? Scroll through our quick slideshow for an overview.


Jesse Noyes

Latest:

The Impact of Ozempic in the US: 3 Takeaways from a Recent Survey

Nearly half of responding medical professionals said patients without T2D have asked for an Ozempic Rx and about 18% of them have provided one, avoiding significant backlash for a denial.


Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP

Latest:

Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab

The panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.


Rebekah Bernard, MD

Latest:

How to Spot and Approach a Colleague in Distress

Mental health issues among health care professionals have always been normal; now that we can acknowledge them, we must, says a family physician and wellness advocate.


Nicholas Pennings, DO

Latest:

Diabetes and Obesity: Why Obesity Treatment Should Come First

An obesity specialist explains why clinicians should start at the root cause when managing patients with type 2 diabetes and obesity.



Denise Myshko

Latest:

More than One-Third of US Adults Say They "Don't Need" Respiratory Virus Vaccines this Fall

Adults saying they don't need immunization this fall have received the vaccines in the past, survey authors report, suggesting a lingering misinformation effect.


Mahesh Krishnan, MD, MPH, MBA

Latest:

The System Isn’t Working for Americans with Kidney Disease

Today, nearly 37 million Americans have chronic kidney disease (CKD), yet only about one percent of those Americans are even aware of their disease. And access to care is under threat.


Isabella Ciccone, MPH

Latest:

Vagus Nerve Stimulation Shows Promise Against Daytime Sleepiness in Narcolepsy: Novel Study

The effect of vagus nerve stimulation persons with narcolepsy revealed a specific, notable improvement in daytime sleepiness in a novel open-label study.


Silas Inman

Latest:

Tirzepatide Ranked Most Effective GLP-1 Mimetic for Obesity Management in New Meta-Analysis

The 2 highest doses of tirzepatide were ranked most likely to be effective for weight management in persons without diabetes, followed by semaglutide 2.4 mg.


Steven Peskin, MD

Latest:

Q&A: Diabetic Retinopathy Screening Devices and Technologies

Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.


Kristian Hurley

Latest:

Type 1 Diabetes: The High Price of Not Knowing

Primary care clinicians can screen at-risk individuals for type 1 diabetes with a single autoantibody panel. It pays to test and educate early, according to this author.


Allen Dobson, Jr, MD, FAAFP

Latest:

Q&A: Diabetic Retinopathy Screening Devices and Technologies

Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.


Bob Kronemyer

Latest:

Parents Negative Beliefs about HPV Vaccination Create Barriers to Adolescent Uptake, a New Study Suggests

Parent's stigmatizing beliefs about the HPV vaccine may keep them from communicating openly with teens' clinicians, creating barriers to getting shots in arms.


Amy Ingersoll, PA-C, MMS

Latest:

Social Determinants of Obesity: Treating Urban & Rural Patients

Social determinants of health vary between patients living in different environments, so what are the key factors to consider when creating a treatment plan?


Kevin Kunzman

Latest:

COVID-19 Infection in Second Trimester May Increase Risk of Preeclampsia, New Study Finds

Data presented at ACOG 2024 suggest SARS-CoV-2 infection early in pregnancy can lead to a higher likelihood of preeclampsia, as well as more severe disease.


Celeste Krewson

Latest:

FDA Approves Femlyv, First Orally Disintegrating Tablet for Birth Control

Femlyv (norethindrone acetate and ethinyl estradiol) may expand access to contraception as an option for individuals with swallowing difficulties.


Patient Care Online Editorial Staff

Latest:

CARDIOLOGY: 2021 Clinical Focus Collection

AHA Scientific Sessions 2021 recap, tests of clinical knowledge, expert interviews, and more in this roundup from Patient Care Online.

© 2024 MJH Life Sciences

All rights reserved.